MRNA: Moderna, Inc. Common Stock
Company identity verified 2026-11-09. Current quotes, news, filings and options load in the terminal; unavailable data is left unavailable.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026.
| Primary exchange (MIC) | XNAS |
|---|---|
| Listed since | 2018-12-07 |
| Market capitalization | $101.5 billion |
| Shares outstanding | 404,620,975 |
| Employees | 4,700 |
| Headquarters | CAMBRIDGE, MA, US |
| Website | www.modernatx.com |
MRNA has traded between $237.65 and $261.00 in the current session, a range of $23.35. The latest price of $254.00 sits in the middle of that range (70% of the way from low to high). It opened at $255.07, a gap up of 1.69% from the prior close of $250.83. The volume-weighted average price is $245.82, and the stock is trading above it. Traders often use VWAP as a gauge of whether buyers or sellers have had the better average entry today.
| Open | $255.07 |
|---|---|
| High | $261.00 |
| Low | $237.65 |
| Previous close | $250.83 |
| Volume | 8,834,598 |
| VWAP | $245.82 |
StockMarketLoop's Market Position model estimates how the shares traded between 2026-08-13 and 2026-11-11 were bought. Its estimate of the average cost basis is $195.86; at $254.00 the stock trades 29.7% above that level. About 92.0% of those shares are estimated to be held at a profit at the current price. A high figure means most recent buyers are in the green, which can mean fewer trapped holders overhead, and also more people with gains who might sell. The densest nearby clusters of cost basis sit around $190.98 (support) and $253.30 (resistance). Roughly 70% of the estimated cost basis lies between $145.15 and $240.47, and 90% between $134.15 and $258.80.
This is a model estimate built from price and volume history, not a record of actual positions.
Quote figures come from StockMarketLoop's market data feed and may be delayed; the timestamp in the summary above shows when they were observed. Company details come from public reference data. The cost-basis section is a statistical model, not a forecast. Nothing here is investment advice; see our financial disclaimer and editorial policy.
Company identity verified 2026-11-09. Current quotes, news, filings and options load in the terminal; unavailable data is left unavailable.